Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

More children are showing signs of hair-pulling disorders during the COVID-19 pandemic due to stress and lack of social interaction.

AGA might indicate higher risk for severe COVID-19.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Some early COVID-19 mutations in patients predicted future common virus mutations.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Long-term effects of COVID-19 can vary over time and are more likely in certain age and gender groups, while race, income, and education levels have little to no impact. Ongoing medical care is needed due to potential complications.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

Public interest in hair loss increased during the COVID-19 pandemic.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

Frankincense may help treat COVID-19, but more research is needed.

Sex hormones may affect COVID-19 severity and outcomes.

Blood type affects COVID-19 infection rates differently in Europe and Africa.

About 61% of women who had COVID-19 experienced hair loss afterward.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.